Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Mar 2007

Jacobi Catharina E, van Ierland Yvette, van Asperen Christi J, Hallensleben Eric, Devilee Peter, Jan Fleuren Gert, Kenter Gemma G

Abstract excerpt

PURPOSE: To describe patient, tumor, and family histories of cancer in a hospital-based cohort of patients with ovarian cancer and to identify the predictive value of these characteristics for (non)carrying a BRCA1 or BRCA2 mutation. METHODS: Women diagnosed with invasive ovarian cancer between 1999 and 2003 in the west region of The Netherlands and unselected for age at diagnosis or cancer family history were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Cohort Studies

Share to DNA Mutational Analysis

Share to Mutation

Share to Ovarian Neoplasms

Share to Predictive Value of Tests

Source

Identifiers

PMID: 17413421
DOI: 10.1097/GIM.0b013e318032e4ab

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.PMID 17413421Read ↗

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.Semantic proximity Read ↗

Risk assessment and genetic testing for ovarian cancer.Semantic proximity Read ↗

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.Semantic proximity Read ↗

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcomeSemantic proximity Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar populationSemantic proximity Read ↗

The contribution of BRCA1 and BRCA2 to ovarian cancer.Semantic proximity Read ↗

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.Semantic proximity Read ↗

Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.Semantic proximity Read ↗

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.